Category: Targeted Research

BACKGROUND: Balancing the effects of dual antiplatelet therapy (DAPT) in the era of potent P2Y12 inhibitors has become a cornerstone of acute coronary syndrome (ACS) management. Recent …

Q: My wife has been using Boluoke® for a number of years now. Even though I am at 69 generally in good health, I was …

Q: I am taking Boluoke® every day, because I have three small Lacunar cerebral infarctions. Will this help?  I am also taking several vitamins at …

INTRODUCTION: There have been reports of clinically relevant uterine bleeding events among women of reproductive age exposed to rivaroxaban. OBJECTIVE: The aim of this study …

ABSTRACT: A subset of patients with coronavirus disease 2019 (COVID-19) become critically ill, suffering from severe respiratory problems and also increased rates of thrombosis. The …

Q: I recently purchased Boluoke®, and was wondering if the supplement still OK if it was subjected to high temperatures (approximately 100 degrees) for an …

BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this “long …

BACKGROUND: Direct oral anticoagulants (DOACs) have shown a positive benefit-risk balance in both clinical trials and real-world data, but approximately 2% to 3.5% of patients …

Q: Does lumbrokinase cross the placental barrier?  Martin G., MD, DC (Jeannette, PA) A: We do not know if lumbrokinase crosses the placental barrier; most …

BACKGROUND: Optimal antiplatelet monotherapy during the chronic maintenance period in patients who undergo coronary stenting is unknown. We aimed to compare head to head the efficacy …